Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
2,246 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Pharmacologic Treatments for Female Menopausal Vasomotor Symptoms: A Systematic Review and Meta-analysis for the American College of Physicians.
Diem S, Landsteiner A, Langsetmo L, Ullman K, Zerzan N, Danan E, MacDonald R, Greer N, Ensrud K, Schousboe J, Drake T, Kaka AS, Wilt TJ. · Ann Intern Med · 2026 · cited 0 timesmeta-analysis, systematic review
- Comparative efficacy and safety of nonhormonal prescription drugs for vasomotor symptoms in women with breast cancer: a systematic review and network meta-analysis.
Liao YS, Deng YP, Song JL, Yu X, Li Q, Lu B, Chen GY. · Front Pharmacol · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Redefining menopausal care: a randomized trial of group CBT for vasomotor symptoms in Korean women.
Jung D, Park JY, Chung KM, Kim MR. · Climacteric · 2026 · cited 0 timesrandomized controlled trial
- A systematic review of heart rate variability and menopausal vasomotor symptoms.
Hira R, Uppal J, Deol P, Porter D, Exner D, Raj SR, Baker JR. · Physiol Rep · 2026 · cited 1 timesOpen accesssystematic review, review-article
- Vasomotor Symptoms and Their Association with Depressive and Anxiety Symptoms in Peri- and Postmenopausal Women: A Systematic Review of Observational Studies.
Neda-Stepan O, Enătescu VR, Giurgi-Oncu C, Bernad ES, Neamțu R, Bernad BC, Kadaș AV, Bredicean C. · Medicina (Kaunas) · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Effectiveness of a digital cognitive behavioral therapy application for vasomotor symptoms in menopausal women: An open-label pilot randomized controlled trial.
Stute P, Pavicic E, Schulze-Wundling K, Kutsojannis H, Green SM, Theis S. · Maturitas · 2026 · cited 0 timesrandomized controlled trial
- Estimated impact of fezolinetant versus placebo on work productivity and indirect costs among women experiencing vasomotor symptoms associated with menopause.
Morga A, Tai TA, Kapoor R, Song W, Hua Q, Hua Y, Yang H, Ajmera M. · Menopause · 2026 · cited 0 timesOpen accessmulticenter study, randomized controlled trial
- Neurokinin pathway botanical antagonist for menopausal vasomotor symptoms: A randomized, double-blind, placebo-controlled study.
Lederman S, Minkin MJ, Doyle AL, Rubio J, Recker S, Lin LX, VanDusseldorp T. · Maturitas · 2026 · cited 0 timesmulticenter study, randomized controlled trial
- The use of conjugated estrogens and bazedoxifene for the management of vasomotor symptoms in premenopausal and menopausal patients with endometriosis: a systematic review.
Mejia-Gomez JC, Shprits E, Sosea C, Leslie B, Mathur S, Farooqi S, Chaudhry A, Bacal V, Essalah A, Shaltout N, Shea A, Sermer C, Hojabri S, Wolfman W, Stancati N, Jacobson M. · Climacteric · 2026 · cited 0 timessystematic review
- Paroxetine versus placebo for the management of vasomotor symptoms in surgical menopause: A pilot double-blind randomized clinical trial.
Álvarez Castro HG, Romero Huete AP, Bu Urbina RE, Cambar-González AR, Gutierrez-Ramirez RA. · Int J Gynaecol Obstet · 2026 · cited 0 timesrandomized controlled trial
- Patient-reported outcome data from a randomized phase II study (STARLIGHT) of fezolinetant in women in Japan with vasomotor symptoms associated with menopause.
Takamatsu K, Miki T, Miyazaki K, Hashimoto A, Morga A, Wang X. · Climacteric · 2026 · cited 0 timesclinical trial, phase ii, multicenter study
- Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical Trial.
Panay N, Joffe H, Maki PM, Nappi RE, Pinkerton JV, Simon JA, Soares CN, Thurston RC, Francuski M, Caetano C, Genga K, Haberland C, Haseli Mashhadi N, Laapas K, Parke S, Seitz C, Schwarz J, Zuurman L. · JAMA Intern Med · 2025 · cited 23 timesOpen accessclinical trial, phase iii, multicenter study
- Curcuminoid supplementation for vasomotor symptoms in postmenopausal women: a pilot, randomized, double-blind, placebo-controlled proof-of-concept trial.
Buntoonprayuk J, Chattrakulchai K, Vallibhakara O, Prasanchit P, Vallibhakara SA. · BMC Complement Med Ther · 2026 · cited 0 timesOpen accessrandomized controlled trial
- Efficacy and safety of GS1-144, a novel neurokinin 3 receptor antagonist, for moderate-to-severe vasomotor symptoms associated with menopause in Chinese women: a randomized, double-blind, placebo-controlled phase 2 trial.
Wang Y, Wang X, Wang W, Lin J, He Y, Chen H, Shou H, Ai X, Zhang Q, Cai Y, Wu Y, Guo R, Hu L, Chen H, Xiang W, Pan C, Yu Q. · Menopause · 2026 · cited 0 timesOpen accessclinical trial, phase ii, multicenter study
- Androgens for genitourinary and vasomotor symptoms associated with menopause.
Lara LA, Cartagena-Ramos D, Cantelli D, Dias CMF, Armstrong S, Jordan V, Fuentealba-Torres M. · Cochrane Database Syst Rev · 2025 · cited 0 timesOpen accesssystematic-review
- Effects of exercise training on vasomotor symptoms and quality of life in postmenopausal women: a randomized controlled trial.
Yilmaz Babacan G, Guler Cekic S, Algun ZC, Durmusoglu AF. · BMC Womens Health · 2025 · cited 2 timesOpen accessrandomized controlled trial
- Relaxation training for vasomotor symptoms and body awareness in menopausal and postmenopausal women.
Sahin G, Pekyavas NO, Aytar A. · J Bodyw Mov Ther · 2025 · cited 0 timesclinical trial
- Elinzanetant: Efficacy and safety in the management of vasomotor symptoms in postmenopausal women, a systematic review and meta-analysis with grading of recommendations assessment, development, and evaluation assessment.
Afifi E, Abdelaziz Ismail R, Ashraf Aldbash A, Ibrahim A, Osama A, Azzam R, Ayman A, Aranda M, Sameh Shaheen R. · Int J Gynaecol Obstet · 2026 · cited 1 timesmeta-analysis, systematic review
- Estetrol (E4) for the treatment of moderate to severe vasomotor symptoms in postmenopausal women - Efficacy and safety results from the phase 3 E4COMFORT I multicenter, placebo-controlled study.
Simoncini T, Bouchard C, Cloes M, Taziaux M, Palacios S, de Medeiros SF, Vrabii V, Archer DF, Panay N. · Maturitas · 2026 · cited 2 timesclinical trial, phase iii, multicenter study
- Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer.
Cardoso F, Parke S, Brennan DJ, Briggs P, Donders G, Panay N, Haseli-Mashhadi N, Block M, Caetano C, Francuski M, Haberland C, Laapas K, Seitz C, Zuurman L. · N Engl J Med · 2025 · cited 46 timesclinical trial, phase iii, multicenter study
- Effect of Exercise Modalities on Post-Exercise Hypotension in Normotensive Postmenopausal Women: A Randomized Controlled Trial on Vasomotor Symptoms Influence.
Bourvellec ML, Delpech N, Sosner P, Fritel X, Bosquet L, Enea C. · Eur J Sport Sci · 2025 · cited 2 timesOpen accessrandomized controlled trial
- Menopausal Hormone Therapy and Cardiovascular Diseases in Women With Vasomotor Symptoms: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Rossouw JE, Aragaki AK, Manson JE, Szmuilowicz ED, Harrington LB, Johnson KC, Allison M, Haring B, Saquib N, Shadyab AH, Rexrode KM, Liu L, Mouton CP, LaCroix AZ. · JAMA Intern Med · 2025 · cited 25 timesrandomized controlled trial, research support, n.i.h., extramural
- Pharmacological Treatments for Menopausal Vasomotor Symptoms: A Systematic Review and Bayesian Network Meta-Analysis of Efficacy and Safety.
Oliveira Amador WF, Saraiva CA, Ruelas MG, Queiroz I, Iqbal A, de Souza Gaio G, Pinilla Alarcón JA, Roberto De Sa J. · Eur J Obstet Gynecol Reprod Biol · 2025 · cited 3 timessystematic review, network meta-analysis
- The Effect of Laughter Yoga on Vasomotor Symptoms and Sleep Quality in Menopausal Women: A Randomized Controlled Trial.
Aksoy-Can A, Güner-Emül T, Değirmenci F, Buldum A, Aksu A, Vefikuluçay-Yılmaz D. · Holist Nurs Pract · 2025 · cited 3 timesrandomized controlled trial
- Efficacy and safety of fezolinetant and elinzanetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis.
de Oliveira HM, Diaz CAV, Barbosa LM, Flávio-Reis VHP, Zamora FV, Gonçalves Barbosa Júnior O. · Maturitas · 2025 · cited 8 timesmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.